Marathi | HIndi
The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
Ekaterina Ivanova - Any safe and effective vaccine against COVID-19 may not need to be administered annually, unlike vaccines for influenza, Dr. Richard Mihigo, the program area manager for immunization and vaccine development at the World Health Organization's (WHO) Regional Office for Africa, told Sputnik in an interview.
The expert committee of Drugs Controller General of India (DCGI) on Friday recommended granting permission to Dr Reddy's Laboratories for conducting phase 2 clinical trials of Russian COVID-19 vaccine candidate, Sputnik V, in India, government officials said.
Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government official said on Tuesday.
Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government official said on Friday.
The Russian Direct Investment Fund on Wednesday confirmed reaching an agreement to supply 100 million doses of Russian COVID-19 vaccine Sputnik V to India's Dr. Reddy's Laboratories.
Venezuelan President Nicolas Maduro said Russia's Sputnik-V vaccine against the novel coronavirus disease (COVID-19) would be delivered to Venezuela in September 2020 for clinical trials.
With Russia approaching India for phase 3 trials of its Sputnik V vaccine against COVID-19 and for its manufacture in the country, NITI Aayog member Dr VK Paul said on Tuesday that the government attaches "great importance to this offer of partnership from a very special friend" and there has been significant movement on both the tracks.
The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.